BIOSIMILAR DRUG CONTRIBUTION TARGET

Workers conduct clean water levels in the laboratory room in one of the biosimilar medicine industry, in Cikarang, West Java, Friday (31/1/2020). Kalbe Farma’s biosimilar drug plant targets the beginning of the drug’s business contribution by 10 percent of the total revenue of prescription drugs, as well as able to meet the needs of biosimilar drugs in Indonesia to 2025. ANTARA PHOTO/Risky Andrianto/hp.

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.